chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Two hours after vax she was vomiting, vomiting stopped next day but pt was complaining of stomach pain. Continued stomach pain and vomiting for a few days until she wasnt able to walk, pt went to ER on 10/15/2021 and she passed in the ER on 10/16/2021
patient presented to emergency department on 10/28/21 with fever, cough and weakness patient was admitted for further management of covid-19 patient was found to be covid-19 positive on 10/28/21 patient did require treatment for symptoms associated with covid-19 infection. treatment included dexamethasone and remdesivir patient was discharged to home on 10/30/21
High fever, chills, nausea, headache and joint muscle pain. Advil helped reducing the fever, had to be taken for three days. Adverse reaction subsided within 48 hours with some headache and weakness lingering for few more days.
My hair is falling out in mass amounts especially worse after my second shot on 09/13/21. The fax number I put is incorrect bc of the time I?m making this report the pharmacy was unopened to give me the number.
Pain deep in upper left arm and shoulder affecting movement. Not severe, but troubling enough to take anti-inflammatory drugs for relief. Also, the injection site did not fully heal for about 10 weeks. It was a small knot on my upper arm with a sore that would not go away. The sore finally healed but the knot is still in my arm. The pain from moving my arm and laying on my arm is still there today (2-15-17). Again, it is not debilitating, but definitely painful enough to force me to make modifications to the way I do certain things.
After the shot, Patient had some chills, and was completely tired. Within the next day or so, she had a terrible migraine headache, with dizziness . After a hot shower, it was a throbbing migraine headache, with dizziness, and vommitting. A day or so later, it was just a terribile migraine. Then after a hot second shower a few days later May 6, it again was a throbbing migraine headache, with dizziness, and vommitting.
This spontaneous report was received from a nurse concerning a 6 months old patient of unknown gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 18-JUN-2015, the patient was vaccinated with an improperly store dose of ROTATEQ injection (lot # K023534, expiration date: 22-MAY-2016) (strength and dose were unspecified) the route was defaulted to oral. No concurrent medications were reported. No adverse effect had been observed or reported. The outcome of the event was unknown. There were no product quality complains (PQC) involved. NO additional information was provided. This is one of several reports received form the same reporter. Additional information has been requested.
The 6 hours after receiving second COVID-19 vaccine my wife experienced  severe weakness and chills. These symptoms initially went away 24 hours later. However, approximately a week later she started having random chills throughout the day with no fever. This is still occurring over 5 weeks later. No other symptoms, just random chills throughout the day and night after waking up.
FEVER, VOMITING, LIGHT HEADED, DIZZY, NO TREATMENT, DISCHARGED HOME FROM ER WITH FOLLOW UP VISIT IN 2 DAYS WITH PCP
Patient had the adverse reaction of a red, itchy, sore arm with a lump. She went to urgent care because the lump was bothering her on day 3, they gave her a steroid shot. She is now experiencing an itchy sensation that began 5 days after the vaccine on a spot on her back where she was affected by shingles 9 years ago. She believes the mild irritation resulted from obtaining the vaccine.
Fever, chills, body aches and severe headache staring around 2am lasting through Friday evening
Immediate strong metallic taste that has not gone away.  High fevers 103, chills and shaking, fatigue, muscle aches and nausea.
4/17/2022 that evening I felt like I was getting a cold. I had a sore throat, achy, tired and a runny nose. The next day, it was worse. I took an at home COVID test that was positive. I had an urgent care visit and discussed PAXLOVID, but my symptoms were mild and the nurse practitioner did not think I needed it. I was sick for about a week. I continued to have chest congestion and a runny nose for two weeks. Then I recovered.
patient reported "itching" feeling at varivax injection site then "light-headedness", then slumped back and was less alert although some response always able to be elicited  throughout. lasted 5 to 18 minutes.
Fever; difficult for him to sleep; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and INSOMNIA (difficult for him to sleep) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and INSOMNIA (difficult for him to sleep). At the time of the report, PYREXIA (Fever) and INSOMNIA (difficult for him to sleep) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Very limited information regarding these events has been provided at this time.  Further information has been requested.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding these events has been provided at this time.  Further information has been requested.
Rashes started all over the body around 10pm.  The patient felt itchy and painful and could not fall asleep for the entire night after the shot. The rashes came back and went away afterwards since then. After taking Benadryl, the symptoms get better.
Three days post vaccination, patient complained of numbness to entire arm. She states this only occurs when she is laying down. It used to wake her up at night. Now, she gets minimal numbness and tingling sensation every 2 or 3 days.
patient was a breastfeeding mother and got a plugged duct resulting in mastitis; patient was a breastfeeding mother and got a plugged duct resulting in mastitis; patient was a breastfeeding mother and got a plugged duct resulting in mastitis; patient was a breastfeeding mother and got a plugged duct resulting in mastitis; This is a spontaneous report from a contactable consumer (patient).  This consumer reported information for both mother and baby. This is the maternal report.   A 29-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 16Apr2021 (lot number: ep 6955) at the age of 29 years old, as single dose for COVID-19 immunisation. Medical history included hypothyroidism and known allergies to sulfa drugs; both from an unknown date and unknown if ongoing. The patient was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. No other vaccines received in four weeks. The patient was a breastfeeding mother and got a plugged duct resulting in mastitis on 18Apr2021 11:45 with outcome of recovering. Therapeutic measures were taken as a result of plugged duct resulting in mastitis and included unspecified antibiotics. The patient was not diagnosed with COVID prior to vaccination. The patient has not been tested for COVID post vaccination.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021452792 same reporter/drug, different patient/event (baby case)
A-fib; This is a spontaneous report received from a contactable reporter(s) (Physician) from medical information team.  A female patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ATRIAL FIBRILLATION (medically significant), outcome "unknown", described as "A-fib". Additional Information: Caller (Doctor) stated she is calling for her neighbor (female, unknow age) who received the Pfizer covid vaccine and in September she experienced A-fib. Her doctor told her that this could be related to Pfizer covid vaccine she received. Caller wanted to know about any reports of A-Fib with the vaccine. She stated she told the patient that her doctor needs to "work up" the patient to find out potential causes of the A-fib.   The lot number for bnt162b2 was not provided and will be requested during follow up. ; Sender's Comments: As there is limited information in the case provided, the causal association between the event atrial fibrillation with the suspect drug Comirnaty cannot be excluded. The case will be reassessed once new information is available.
dizziness, ringing of ears, cold & hot, nausea, diarrhea 3 loose stools, fatigue, no appetite, trouble sleeping;
9 x 14 mm erythema, edema (R) upper arm non-tender site occurred 40- 48 hours after injection ice applied to (R) upper arm by parent.
Called clinic to report 1 hr post injection - muscle soreness in L arm and neck. Had fever 100.4F took advil, temp dropped to 99F. Restless noc headache & sore arm., this am T 102.4F, sore arm & severe headache. Pt admitted to having tightness in throat (hard to swallow when waking) on 6/5/01 partner had sore throat also.
Patient felt tightness in throat.  No distress except for lump in throat.  Had patient sit for observation.  Patient called her physician.  Advised to give Edipen and Diphenhydramine 50 mg.  Had patient stay 30 min.  No change.  Sent back to work in taxi.  Called next morning.  Patient was fine.
Couple of cysts on the arm and underarm area; Rash showing up a week later /Rash is the size of a baseball; muscle soreness; Minor reactions; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Minor reactions), CYST (Couple of cysts on the arm and underarm area), RASH (Rash showing up a week later /Rash is the size of a baseball) and MYALGIA (muscle soreness) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE REACTION (Minor reactions) and MYALGIA (muscle soreness). On 25-Mar-2021, the patient experienced CYST (Couple of cysts on the arm and underarm area) and RASH (Rash showing up a week later /Rash is the size of a baseball). At the time of the report, VACCINATION SITE REACTION (Minor reactions), CYST (Couple of cysts on the arm and underarm area), RASH (Rash showing up a week later /Rash is the size of a baseball) and MYALGIA (muscle soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medication was reported Patient didn't receive any treatment
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 59-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 27Dec2020 as dose 1, single (Lot number: EK9231), in left arm, on 17Jan2021 as dose 2, single (Lot number: EL1283), in left arm and on 21Dec2021 as dose 3 (booster), single (Lot number: FF2590) at the age of 59 years, in left arm for covid-19 immunisation. Relevant medical history included: "Hypertension" (unspecified if ongoing); "SULFA allergy" (unspecified if ongoing). Concomitant medication(s) included: COZAAR; ZYDUS; VITAMIN D 2000; ACETAMINOPHEN; FOLIC ACID; B-12; ESTROVEN; TURMERIC CURCUMIN.  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19 Treatment". Therapeutic measures were taken as a result of vaccination failure, covid-19 with paxlovid (lot number: FY9928) from 11May2022 to 16May2022. Clinical course: The patient was taking other medications/products within 2 weeks of starting COVID-19 treatment. The patient was taking as concomitant therapy.; Sender's Comments: Based on the information available , a possible contributory role of the suspect  BNT162b2 cannot be excluded for the reported events of covid-19 and vaccination failure.
pt was unable to walk on leg PM 7DEC92; leg was reddened & swollen; pt was taken to family the PM 7DEC92; pt recommended cont APAP;
Hives, swelling, erythema - by next day (within 12 hours) progressive rash with welts over next 36 hours at time of clinic visit.
Extreme pain at injection site on are, headache, nausea, vomiting, lethargic.
Sore arm; headache at back of head overnight; Chills; tired; This is a spontaneous report from a contactable consumer.  A 74-year-old male patient received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: E29264), via an unspecified route of administration in the left arm on 08Feb2021 at 10:45 at 74-years-old at a single dose for COVID-19 immunization; administered in a school or student health clinic. The patient did not receive any other vaccine within four weeks of the suspect vaccine. Medical history included recent prostatectomy on an unknown date, and lactose intolerant from an unknown date and unknown if ongoing. The patient did not have COVID prior to the vaccination. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), aspirin [acetylsalicylic acid] (ASPIRIN [ACETYLSALICYLIC ACID]), metoprolol (MANUFACTURER UNKNOWN), hydrochlorothiazide, valsartan (MANUFACTURER UNKNOWN); all taken for an unspecified indication from an unspecified date to an unspecified date; received within two weeks of the suspect vaccine. On 08Feb2021 at 20:00, the patient experienced: sore arm (non-serious), headache at back of head overnight (non-serious), chills (non-serious), tired (non-serious); with no treatment received.  The clinical outcome of the events was recovered on an unspecified date. The patient was not tested for COVID post vaccination.
Pfizer vaccine #1 given 5/15/21, lot # EW0185; Pfizer vaccine #2, lot # EW0178; pt was admitted to the medical center from 1/11/22 - 2/11/22 after LOC while transferring to toilet; c/o diarrhea; found to be positive for COVID; pt has malnutrition and debility; A Fib with RVR; NSTEMI; transferred to PCU; comfort focused; DNR/DNI; pt never required O2; was given remdesivir; transferred to hospice facility where she passed away
swelling of upper lip; Swelling of cheeks; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Swelling of cheeks) and LIP SWELLING (swelling of upper lip) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included Blood pressure medicine..    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, the patient experienced SWELLING FACE (Swelling of cheeks). On an unknown date, the patient experienced LIP SWELLING (swelling of upper lip). At the time of the report, SWELLING FACE (Swelling of cheeks) and LIP SWELLING (swelling of upper lip) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
elevated anxiety overnight; This spontaneous case was reported by an other health care professional and describes the occurrence of ANXIETY (elevated anxiety overnight) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Anxiety (Patient was diagnosed and was on medication for Anxiety.).    On 02-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANXIETY (elevated anxiety overnight). At the time of the report, ANXIETY (elevated anxiety overnight) outcome was unknown.            Patient was on medication for anxiety. No treatment medications were provided.
Mother and Pt informed about what vaccines she was getting and advised to wait 15 min after. Immediately after giving vaccines (without problems) Pt started to faint fell off mother's legs-RN and mother placed her on exam table. Pt came to an vital signs assessed and provider evaluated. Pt recovered within 15 min.
Had a sore throat and body aches, took a home COVID-19 test and was positive. Went to Urgent Care and was prescribed Paxlovid and given Mucinex. Started feeling better soon after.
had 100 fever; pain and redness at site of injection; pain and redness at site of injection; This is a spontaneous report received from contactable reporter(s) (Physician) from a sales representative.  A 45-year-old male patient received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), as dose 1, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history included: "Diabetic" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "had 100 fever"; VACCINATION SITE PAIN (non-serious), VACCINATION SITE ERYTHEMA (non-serious), outcome "unknown" and all described as "pain and redness at site of injection". The patient underwent the following laboratory tests and procedures: Body temperature: 100, notes: had 100 fever.  Additional information: Event took place after use of product. 45 yo diabetic male pt received Prevnar20 as directed and had 100 fever, pain and redness at site of injection.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
A patient had an adverse reaction following receiving a flu vaccination at a flu clinic held at this morning (9/23/21).  Immediately following vaccine given, patient became unresponsive for approximately 30-45 seconds- muscles tightened, skin cool and diaphoretic. Patient became alert, but skin remained pale. Was given OJ and cold compress. EMS was contacted, they came and evaluated the student. Did not transport him. Patient reports as well as his father that was a staff member who was present with him that he has a history of fainting after receiving shots at PCP office.
FATIGUE; SORE ARM; CHILLS; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, and batch number: 1805020 expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-MAR-2021, the subject experienced sore arm. On 12-MAR-2021, the subject experienced chills. On 12-MAR-2021, the subject experienced injection site pain. On 13-MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and was recovering from injection site pain, fatigue, and sore arm. This report was non-serious.
received the Moderna Covid-19 vaccine for her primary series and that 2 months ago she tested positive for Covid-19.; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (received the Moderna Covid-19 vaccine for her primary series and that 2 months ago she tested positive for Covid-19.) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (received the Moderna Covid-19 vaccine for her primary series and that 2 months ago she tested positive for Covid-19.). At the time of the report, COVID-19 (received the Moderna Covid-19 vaccine for her primary series and that 2 months ago she tested positive for Covid-19.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Positive) Positive.         The caller reports that she received the Moderna Covid-19 vaccine for her primary series and that 2 months ago she tested positive for Covid-19. The patient did not provide any dates of vaccination, lot numbers or expiration dates of vaccines. The patient did not provide her date of birth or age. No concomitant medication information were given. No treatment information were given.  Company comment- This spontaneous case concerns a female patient of unknown age with no reported medical history, who experienced unexpected, non-serious AESI Covis-19 (with positive Sars-CoV test), which occurred at an unknown time with regards to the mRNA-1273 vaccination. No further information was provided. The outcome of the events was reported as unknown. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   Reporter did not allow further contact; Sender's Comments: This spontaneous case concerns a female patient of unknown age with no reported medical history, who experienced unexpected, non-serious AESI Covis-19 (with positive Sars-CoV test), which occurred at an unknown time with regards to the mRNA-1273 vaccination. No further information was provided. The outcome of the events was reported as unknown. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
pt recv vax 18JAN93 & 25JAN93 pt exp fever of 105, convuls & rash;
INJECTION SITE TENDERNESS, FATIGUE, BACK PAIN Narrative:  Other Relevant History: